Cambridge Investment Research Advisors, Inc. - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 238 filers reported holding IMMUNOGEN INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$339
-23.3%
21,362
-8.8%
0.00%0.0%
Q2 2023$442
+124.4%
23,433
-54.4%
0.00%
+100.0%
Q1 2023$197
-21.8%
51,401
+1.3%
0.00%0.0%
Q4 2022$252
-99.9%
50,765
-5.0%
0.00%0.0%
Q3 2022$256,000
+6.2%
53,463
-0.2%
0.00%0.0%
Q2 2022$241,000
+81.2%
53,563
+91.5%
0.00%0.0%
Q1 2022$133,000
-35.7%
27,974
+0.4%
0.00%0.0%
Q4 2021$207,000
+95.3%
27,875
+49.2%
0.00%0.0%
Q3 2021$106,000
-5.4%
18,687
+7.6%
0.00%0.0%
Q4 2020$112,000
+55.6%
17,373
-12.5%
0.00%
Q3 2020$72,000
-20.9%
19,866
+0.5%
0.00%
-100.0%
Q2 2020$91,000
+35.8%
19,7660.0%0.00%0.0%
Q1 2020$67,000
-75.5%
19,766
+7.7%
0.00%
-90.0%
Q1 2014$274,000
+21.2%
18,358
+19.1%
0.01%
+11.1%
Q4 2013$226,000
-9.6%
15,408
+4.8%
0.01%
-18.2%
Q3 2013$250,000
+8.2%
14,708
+5.8%
0.01%
-8.3%
Q2 2013$231,00013,9080.01%
Other shareholders
IMMUNOGEN INC shareholders Q4 2021
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders